iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.74
0.06 (9.14%)
At close: Aug 15, 2025, 3:59 PM
0.75
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

iBio Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-24.91M -65.01M -50.3M -23.21M
Depreciation & Amortization
1.25M 1.38M 3.79M 2.41M
Stock-Based Compensation
2.04M 4.39M 4.38M 1.59M
Other Working Capital
-1.68M 6.51M 6.76M -11.55M
Other Non-Cash Items
6.23M 167K 1.41M -56K
Deferred Income Tax
n/a 22.77M n/a 359K
Change in Working Capital
-3.17M 5.87M 3.24M -11.15M
Operating Cash Flow
-18.55M -30.44M -37.48M -30.06M
Capital Expenditures
-210K -5.74M -11.63M -5.16M
Cash Acquisitions
n/a -692K -7.56M -242K
Purchase of Investments
n/a -10.15M -7.12M -23.82M
Sales Maturities Of Investments
n/a 10.84M 13.62M 4M
Other Investing Acitivies
1.12M 12.75M 7.56M -1.26M
Investing Cash Flow
906K 7.01M -5.13M -26.48M
Debt Repayment
-1.14M -9.13M -5.83M -331K
Common Stock Repurchased
-7K -39K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
197K -22K -295K 890K
Financial Cash Flow
24.49M 2.3M -6.13M 78.83M
Net Cash Flow
6.85M -21.09M -48.73M 22.29M
Free Cash Flow
-18.76M -36.17M -49.11M -35.23M